NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 321 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $293,032 | -29.4% | 7,061 | +2.3% | 0.20% | -30.2% |
| Q1 2023 | $415,026 | -25.6% | 6,901 | -9.2% | 0.28% | -31.3% |
| Q4 2022 | $557,753 | +3.1% | 7,604 | +6.9% | 0.41% | -7.3% |
| Q3 2022 | $541,000 | +9.1% | 7,116 | -0.2% | 0.44% | +8.1% |
| Q2 2022 | $496,000 | -13.7% | 7,132 | +2.7% | 0.41% | -16.9% |
| Q1 2022 | $575,000 | -16.1% | 6,943 | -28.9% | 0.49% | -11.4% |
| Q4 2021 | $685,000 | – | 9,767 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |